Archive for Tag: COVID-19

Johnson & Johnson

J&J vaccine drive stalls out in U.S after safety pause

Johnson & Johnson (NYSE:JNJ) is trading down 0.04% at 165.97 Safety concerns about Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting...

Read More
AstraZeneca Stock Price

UK competition regulator looking into $39 billion AstraZeneca-Alexion deal

AstraZeneca (NASDAQ:AZN) is trading down 0.26% at 8129.00 Britain’s competition regulator is reviewing AstraZeneca (NASDAQ:AZN)’s $39 billion buyout of U.S.-based Alexion (NASDAQ:ALXN) on concerns it could reduce competition in the UK market or elsewhere. The UK’s Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from...

Read More

Oxford Biomedica lifts outlook as AstraZeneca ramps up vaccine output

AstraZeneca (NASDAQ:AZN) UP 0.62% AT 7944 Oxford Biomedica on Tuesday doubled the revenue expectation from its COVID-19 vaccine supply deal with AstraZeneca (NASDAQ:AZN) after the drug maker commissioned more batches from the company in the second half of 2021. Shares of the cell therapy firm, which has an agreement...

Read More
BioNTech

BioNTech to build mRNA vaccine manufacturing site in Singapore

BioNTech plans to set up a regional centre and a new factory in Singapore for its vaccines, it said on Monday, boosting its presence in Asia as a debate over patents rages and pressure grows on drugmakers to raise output of COVID-19 shots. Governments are looking to build up...

Read More